Merck Stock Price

-2.07 (-1.87%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 9,667,523
Bid Price
Ask Price
News -
Day High 111.37


52 Week Range


Day Low 108.745
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.07 -1.87% 108.78 19:31:39
Open Price Low Price High Price Close Price Prev Close
110.78 108.745 111.37 108.78 110.85
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
87,320 9,667,523 $ 110.09 $ 1,064,303,504 - 71.97 - 111.37
Last Trade Time Type Quantity Stock Price Currency
19:58:27 6 $ 108.78 USD


Draw Mode:

Merck and Co Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 275.80B 2.54B 2.53B $ 50.16B $ 12.97B 5.14 18.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 2.64 2.65% 12/14/22 -2.92M 0.10%

more financials information »

Merck News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week109.00111.37108.42109.987,395,649-0.22-0.2%
1 Month100.53111.3797.33106.128,822,6148.258.21%
3 Months86.61111.3784.5297.429,200,16822.1725.6%
6 Months89.15111.3783.0593.159,355,81719.6322.02%
1 Year73.53111.3771.9786.9410,735,29235.2547.94%
3 Years89.14111.3765.2581.5911,103,80519.6422.03%
5 Years55.57111.3752.8377.8910,708,02253.2195.75%

Merck Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.